RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD

Clinical trial NCT02128113 · COMPLETED

Trial details

NCT number: NCT02128113
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Corneal Endothelial Cell Loss Ocular Pain Ocular Inflammation Cataract Surgery

Start date: 2014-05-31
Primary completion: 2015-02-28
Enrollment: 307

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.